GMP CDMO Reach Eurogentec operates as a GMP manufacturing partner under FDA and EMA guidelines with capabilities spanning oligonucleotide GMP production, proteins, plasmids, and vaccines. This positions them as a potential contract manufacturing organization (CDMO) for customers seeking scalable, compliant biologics and gene therapy components.

Kaneka Backbone As part of the Kaneka Corporation, Eurogentec benefits from a larger corporate platform that can provide credibility, support, and cross-sell opportunities across Europe and beyond, particularly to customers already aligned with Kaneka’s materials and services.

Diagnostics & qPCR With a dedicated In Vitro Diagnostics unit and experience developing qPCR reagents, Eurogentec is well-positioned to engage biopharma and diagnostic developers needing specialized reagents, assay kits, and production for molecular diagnostic applications.

Genomics Proteomics Stack Strong capabilities in genomics oligonucleotides, PCR/qPCR kits, custom peptides and antibodies create cross-sell opportunities to research institutes and biotech firms expanding genomics and proteomics pipelines, including lab-to-clinic workflows.

Global Compliance ISO 9001, ISO 13485, cGMP, and FDA inspection approvals highlight robust quality systems and compliance, making Eurogentec a favorable partner for customers prioritizing regulatory readiness and scalable manufacturing for clinical and commercial products.